Rockwell Medical (RMTI) Enterprise Value (2010 - 2026)
Rockwell Medical (RMTI) posted Enterprise Value of -$23.9 million for Q1 2026, up 4.43% on a QoQ basis from -$25.0 million in Q4 2025, and down 37.85% year-over-year from -$38.4 million in Q1 2025.
Rockwell Medical (RMTI) Enterprise Value (2010 - 2026) Analysis & Trends
Rockwell Medical's Enterprise Value history runs 17 years deep, the most recent figure standing at -$23.9 million for Q1 2026.
- Quarterly Enterprise Value fell 37.85% year-over-year to -$23.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$23.9 million (down 37.85% YoY) and the FY2025 annual result came in at -$25.0 million, down 15.72% from the prior year.
- Enterprise Value was -$23.9 million for Q1 2026 at Rockwell Medical, up from -$25.0 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$8.6 million in Q1 2024 and bottomed at -$30.8 million in Q2 2022.
- A 5-year average of -$18.4 million and a median of -$18.3 million in 2024 frame the typical range for Enterprise Value.
- Annual changes were most pronounced in 2022 — Enterprise Value jumped 78.54% — and 2025, when it sank 101.08%.
- Rockwell Medical's Enterprise Value stood at -$21.5 million in 2022, then soared by 49.12% to -$10.9 million in 2023, then plunged by 97.55% to -$21.6 million in 2024, then fell by 15.72% to -$25.0 million in 2025, then gained by 4.43% to -$23.9 million in 2026.
- Business Quant data shows RMTI's Enterprise Value at -$23.9 million in Q1 2026, -$25.0 million in Q4 2025, and -$23.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | -1.86 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -3.74 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -1.94 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -4.05 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -2.15 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | -33.59 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -1.80 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -1.32 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -428.00 Mn |
| 10 | Rockwell Medical | 25.77 Mn | 1.88 Mn | 2.90 Mn | -23.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -23.89 Mn |
| Dec 31, 2025 | -25.00 Mn |
| Sep 30, 2025 | -23.71 Mn |
| Jun 30, 2025 | -18.42 Mn |
| Mar 31, 2025 | -17.33 Mn |
| Dec 31, 2024 | -21.60 Mn |
| Sep 30, 2024 | -18.27 Mn |
| Jun 30, 2024 | -11.86 Mn |
| Mar 31, 2024 | -8.62 Mn |
| Dec 31, 2023 | -10.94 Mn |
| Sep 30, 2023 | -11.73 Mn |
| Jun 30, 2023 | -14.87 Mn |
| Mar 31, 2023 | -16.83 Mn |
| Dec 31, 2022 | -21.49 Mn |
| Sep 30, 2022 | -27.56 Mn |
| Jun 30, 2022 | -30.78 Mn |
| Mar 31, 2022 | -9.90 Mn |
| Dec 31, 2021 | -22.44 Mn |
| Sep 30, 2021 | -33.20 Mn |
| Jun 30, 2021 | -40.95 Mn |